Best fit for shoppers who avoid needles: An at-home PDRN cream matches a no-needle preference because it is applied to the skin, while a PDRN skin-booster procedure uses professional delivery into the skin.
- Abib’s PDRN Volume fill-it Booster crème 2.5 tube combines PDRN, Volufiline, retinal, and peptides in a cosmetic cream.
- Abib describes appearance-focused aims for hollow areas, wrinkles, firmness, and elasticity.
- A cream and an injection are different routes, with different evidence and appointment needs.
For US shoppers, Dermatology Times reports that injectable PDRN is not FDA-approved for cosmetic use in the United States.
The key difference is delivery route
PDRN and PN are labels for related DNA-based chains, but the terms do not always mean the same chain length. A 2025 review in Biomolecules says publications have sometimes used PDRN and PN interchangeably. The authors propose calling chains below 1,500 kilodaltons PDRN and chains at or above that size PN, while describing this as a proposed naming standard rather than a universal convention.
A clinic skin-booster procedure delivers material into the skin, usually by injection; some professional protocols use microneedling or another device-assisted route. An at-home cream is spread on the skin’s surface. A dermatology review in the Journal of Cutaneous and Aesthetic Surgery describes creams, serums, and other topical forms as non-invasive, while noting that topical penetration may be limited compared with injection.
A 2026 systematic review of randomized studies included seven studies and 183 participants across skin rejuvenation, post-procedure scars, and wound care. One appearance study included 29 women with periorbital wrinkles and compared topical PN plus radiofrequency microneedling with radiofrequency microneedling plus saline over six months.
A randomized split-face comparison involving 27 people evaluated injectable Rejuran against hyaluronic-acid filler; the PDRN/PN side had higher Global Aesthetic Improvement Scale scores at 16 weeks and a greater reduction in skin roughness at week 28, according to Dermatology Times. A late-2025 study of topical low-molecular-weight peony PDRN reported improved periorbital elasticity after four weeks, according to Dermatology Times.
The 2026 review found that studies varied in populations, formulations, delivery methods, outcome measures, and follow-up periods. The reviewers summarized findings narratively rather than combining them into one pooled treatment estimate.
What a US clinic procedure involves
An injectable route means an appointment with a qualified professional and skin puncture. The Aesthetic Society’s injectable safety guidance recommends a qualified clinician, an appropriate setting with sterile instruments, and a consultation that covers individual risks and benefits. It also advises patients to share their medical conditions and medications, including vitamins and over-the-counter products.
Ask the provider to name the exact product and explain its US status before discussing a schedule. The Aesthetic Society advises patients to know what product is being injected and recommends FDA-approved products purchased in the United States. For PDRN specifically, Dermatology Times reports that injectable PDRN is not FDA-approved for cosmetic use in the US, so a clinic’s description of the product and its regulatory status deserves a direct question.
The FDA explains that cosmetics generally do not need FDA approval before sale, apart from color additives, although laws and regulations still apply. The FDA describes its authority over cosmetics as different from its authority over drugs, biologics, and medical devices.
The number of visits and the overall price depend on the provider’s proposed plan. A PDRN cost overview from SkinCeuticals gives a US estimate of $200 to $500 for one injection session; the page was reviewed October 3, 2026, and says location, provider, and number of sessions affect the final amount. A consultation can help you understand the exact product, proposed delivery method, visit count, total quote, and recovery instructions for that procedure.
What an at-home PDRN cream can offer
A home cream suits someone who wants a topical cosmetic in their regular skincare routine and prefers to avoid a procedure. It is bought as a product and applied at home, rather than administered by a provider. Follow its label directions and judge it by the cosmetic claims made for that formula.
Abib describes its PDRN Volume fill-it Booster crème 2.5 tube as a topical booster formulated with PDRN, Volufiline, retinal, and peptides. Its product copy lists PDRN at 15,000 ppm and Volufiline at 10,000 ppm. Abib says the cream helps visibly plump hollow areas and improve the appearance of wrinkles, skin firmness, and elasticity, with target areas including the forehead, smile lines, under-eyes, and neck.
Abib’s appearance claims describe a multi-ingredient formula that combines PDRN and Volufiline with retinal and peptides. The listed ppm figure describes ingredient concentration, while molecular weight describes the size of a DNA chain. The Biomolecules review recommends low-molecular-weight PDRN for topical creams or gels and PN or medium-molecular-weight PDRN for injectable hydrogels.
Compare access, schedule, recovery, and cost
| Decision point | Clinic-administered PDRN/PN procedure | At-home PDRN cream |
|---|---|---|
| Delivery | Professional skin-booster injections place material into the skin; some studies also examine provider-assisted delivery with devices. | Abib’s PDRN Volume fill-it Booster crème is a topical cream applied at home. |
| Access and schedule | Requires a qualified provider and consultation; the visit count and schedule depend on the proposed plan. | No procedure appointment; apply the product at home according to its label. |
| Public price example | SkinCeuticals estimates $200 to $500 per US injection session on a page reviewed October 3, 2026; the total depends on location, provider, and number of sessions. | Abib’s US listing showed a sale price of $23.80 and a regular price of $28 per tube on October 2, 2026. |
| What the evidence describes | The 2026 systematic review includes topical PN used with radiofrequency microneedling; Dermatology Times reports a split-face injectable Rejuran comparison. | Abib describes its cream with cosmetic appearance claims; the reported topical peony study used low-molecular-weight PDRN. |
If you use SkinCeuticals’ $200 to $500 US per-session estimate and assume three visits, the session fees would total $600 to $1,500 before separately quoted fees.
Abib’s listing gives a price per tube. That price covers one product purchase; a shopper’s total over a given period depends on how often they use and repurchase it. A practical budget comparison sets the provider’s total plan beside the number of cream tubes you would buy over the same period.
SkinCeuticals describes possible injection-site redness, swelling, or bruising after PDRN injections, usually resolving within a few hours to a couple of days. A proposed schedule, recovery plan, or total cost that does not fit your constraints makes the home route the more practical match for a needle-averse shopper.
Choose the route that fits your needle preference
For a shopper who wants no needles, a topical cream is the direct fit. Abib’s booster crème offers a specific PDRN cosmetic option with Volufiline, retinal, and peptides, plus appearance claims for hollow areas, wrinkles, firmness, and elasticity.
A clinic procedure fits a shopper who specifically wants provider-administered delivery and accepts skin puncture, consultation, cost, and product-status questions. In the US, the reported lack of FDA approval for injectable PDRN for cosmetic use makes it especially important to identify the exact injectable product and ask how the provider handles that status. Someone who is not comfortable with needles or cannot confirm the product and full visit plan has a clear reason to choose a topical routine instead.
Use these questions before booking or buying:
- Can my location and calendar accommodate the provider’s consultation and proposed visits?
- Does the provider identify the exact product and explain its US status for the intended use?
- Does the full quoted plan, including any separate fees, fit my budget?
- Does the cream’s label and its appearance goals fit the home routine I want?
FAQ
Is an at-home PDRN cream equivalent to an injectable procedure?
No. The cited randomized comparison evaluated injectable Rejuran against hyaluronic-acid filler, while the review’s topical-PN appearance study paired the ingredient with radiofrequency microneedling; Abib describes a cream for home use.
Does 15,000 ppm tell me how deeply Abib’s cream delivers PDRN?
No. The ppm figure is a concentration claim from the product listing. Molecular weight and delivery method are separate details that influence how a topical and injectable formula should be compared.
Is injectable PDRN FDA-approved for cosmetic use in the United States?
No. Dermatology Times reports that injectable PDRN is not FDA-approved for cosmetic use in the United States. For cosmetics, the FDA says premarket approval is generally not required, except for color additives.
What should I ask a clinic before booking?
A consultation should assess whether the procedure fits your skin concerns and explain the individual risks and benefits. The Aesthetic Society advises patients to discuss the product, provider, setting, and individual risks before an injection.